Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2024年9月25日
	新闻
	Study Proves Accuracy Of Median Technologies' Lung Cancer Diagnostic Medical Product Outsourcing The firm's proprietary artificial intelligence (AI)/machine learning (ML)-powered Software as Medical Device (SaMD) lung cancer screening (LCS) tool ... 标记为不相关
	FDA approves osimertinib for locally advanced, unresectable (stage III) non-small cell lung ... FDA ... (Tagrisso, AstraZeneca Pharmaceuticals) for adult patients with locally advanced, unresectable (stage III) non-small cell lung cancer. 标记为不相关
	AstraZeneca Gets US FDA Approval for Tagrisso for Lung Cancer - Bloomberg Law News Bloomberg Law News ... Tagrisso (osimertinib) for some adult patients with locally advanced, unresectable non-small cell lung cancer, the agency said on its website. 标记为不相关
	FDA Approves Post-Chemoradiation Osimertinib for Advanced NSCLC - Oncology Nursing News Oncology Nursing News The FDA approved osimertinib for locally advanced, unresectable stage III EGFR-mutated non-small cell lung cancer. 标记为不相关
	FDA Approves Osimertinib in Stage III EGFR-Mutated NSCLC - Targeted Oncology Targeted Oncology The FDA approved osimertinib (Tagrisso) for the treatment of patients with stage III EGFR-mutated non–small cell lung cancer (NSCLC) whose disease ... 标记为不相关
	FDA Approves Osimertinib for Locally Advanced, Unresectable EGFR+ NSCLC After Chemoradiation OncLive The FDA approved osimertinib for EGFR-mutated, locally advanced, unresectable, non–small cell lung cancer after chemoradiation. 标记为不相关
	FDA Approves Tagrisso for Some With Advanced NSCLC - Cure Today Cure Today Tagrisso has been approved for some adults with locally advanced, unresectable stage 3 non-small cell lung cancer. 标记为不相关
	Non-Operative Management of Rectal Cancer Does Not Worsen Distant RFS Oncology Nursing News - OncLive Belrestotug/Dostarlimab Improves Responses in PD-L1–High Lung Cancer ... Belrestotug plus dostarlimab-gxly improved ORR in patients with previously ... 标记为不相关
	Adagrasib Improves Response in KRAS G12C-Mutated NSCLC - HMP Global Learning Network HMP Global Learning Network Conference Coverage. Adagrasib Improves Response Among Patients With KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer. Stephanie Holland. 09/25/ ... 标记为不相关
	Clinical Application of New Risk-Based Cancer Screening in Patients With Dermatomyositis JAMA Network Lung Cancer Assistant: a hybrid clinical decision support application for lung cancer care. M. Berkan Sesen, Interface, 2014. A new eudiometer ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈